An article by Walter O. Cofffey, MPA, MA goes into Dementia and Drugs, and the change of dementia care. A new paradigm is dramatically changing dementia care, turning a critical eye toward the conventional use of behavior-altering medications and increasingly considering the individual person.
About Antipsychotic Drugs
The inappropriate antipsychotic drugging of nursing home residents, particularly those with dementia, is a widespread, national problem. “Close to 20 percent of nursing home residents (over a quarter of a million people) are given powerful and dangerous antipsychotics despite a ‘Black-Box’ warning that they are associated with increased risk of death in older adults”.
Antipsychotic drugs are used as a quick fix to address and quell unwanted “behaviors” in people with dementia. In our society, we have developed the expectation of quick fixes. This is true in medical care as well. Physicians are expected to prescribe a drug to quickly address any problem. As people with dementia experience changes in their condition, often these commonly called “negative behaviors” become more evident and happen more frequently. This is especially true when the ability to verbally communicate changes. It can be frustrating for all care partners. Family members ask for drugs that will “control” their loved one’s “negative behaviors.” Staff in nursing homes and other congregate settings often do the same thing, especially when they have not been educated and empowered to try other approaches first.
Antipsychotic medications are highly potent drugs that work in the brain to block certain chemicals that can cause symptoms of psychosis, such as hallucinations and delusions. These drugs are most often used with illnesses like schizophrenia, bipolar disorder, Huntington’s disease, or Tourette syndrome. They include drugs such as Risperdal, Haldol, Abilify, and Seroquel.
These drugs are frequently used to treat so-called behavioral and psychological symptoms of dementia and are often used as a chemical restraint. The drugs sedate residents so that not only their behavior, but also the underlying causes for that behavior, do not have to be addressed by staff.
Suppressing behavior makes it impossible to uncover the root cause of what is actually producing the symptoms of distress. These drugs do not address memory problems. They also do not help people with dementia to:
- stop yelling
- stop repeating the same questions over and over
- do more for themselves
- interact better with others
- stop saying inappropriate things
- become less restless.
In 2005, the Food and Drug Administration (FDA) issued the “Black-Box” warning requiring drug companies to label antipsychotics with their side effects and potential dangers. In addition to “destroying social and emotional well being including the loss of independence, these drugs greatly increase risks of stroke, heart attack, diabetes, Parkinsonism, and falls. They are NOT clinically indicated for dementia related psychosis. They ARE associated with a significant increase in death when given to older people with dementia”
“BLACK-BOX” WARNING ISSUED BY FDA
WARNING:
Increased Mortality in Elderly Patients with Dementia Related Psychosis. Elderly patients with dementia related psychosis treated with antipsychotic drugs are at an increase risk of death. { Name of Antipsychotic} is not approved for the treatment of patients with dementia-related psychosis